26Oct 2022
Factors associated with successful weight loss after liraglutide treatment for obesity

Factors associated with successful weight loss after liraglutide treatment for obesity

To identify patient factors, including gastrointestinal functions, that are predictive or associated with weight loss in response to once‐daily 3 mg liraglutide administered subcutaneously (SQ) or placebo in obesity. Slower GET1/2 and weight loss at 5 weeks predicted a weight loss of more than 4 kg at 16 weeks in all participants. Among liraglutide‐treated adults, weight loss of more than 4 kg was associated with ad libitum meal kcal intake at 16 weeks.

  • #endo-diabetology

Like

Save

Share